Dara Offrede

Attorney

Bio

Dara's practice concentrates on high-complexity transactional, regulatory and intellectual property matters, with a focus on the pharmaceutical, MedTech and agribusiness industries. With deep understanding of the regulatory and market practices in Brazil, Dara has a proven track record of providing vital guidance to clients, ensuring strategic protection of their business interests. This includes strategic advice and support on all stages of a product's lifecycle, from clinical trials to commercialization, and the enforcement of IP rights for medicines, biological products, medical devices e agriculture products. 

 

As a skilled litigation attorney, Dara experience also includes handling complex litigation against regulatory and government agencies such as the Brazilian Health Regulatory Agency (Anvisa), the Brazilian Drug Market Regulation Chamber (CMED) and the Ministry of Agriculture, Livestock, and Food Supply (Mapa).

Education

- J.D. from Universidade do Estado do Rio de Janeiro (UERJ).

- Specialization candidate in Regulatory Law at Universidade do Estado do Rio de Janeiro (UERJ) - expected graduation: 2026.2.

Languages

Portuguese, English, French

Publications

Life Sciences & Healthcare Patents
Life Sciences & Healthcare Patents

ANVISA new rules allowing changes on marketing approval “waiting list”

ANVISA’s new 2025–2026 Operational Tactical Plan aims to reduce marketing approval backlogs by allowing applicants to replace pending submissions before formal review and by granting priority review for GLP‑1 receptor agonists.
2025
5
min read